When does the ivermectin patent (or key exclusivity) expire?
Ivermectin is an older antiparasitic drug first developed in the late 1970s, and its original patents in the US and many other jurisdictions have long since passed. What remains in the market today are typically later filings tied to specific formulations, strengths, dosing routes, or country-specific regulatory exclusivities rather than the original “core” ivermectin patent.
If you are trying to figure out a specific “when does the patent expire” date, the answer depends on which product you mean (for example, tablets vs. oral solution vs. topical use, and which brand/generic market), because those can be protected by different patents and exclusivities.
Which ivermectin patents matter most for generics and biosimilar-style entry?
For an older drug like ivermectin, generic entry is usually affected by:
- Reformulation patents (different dosage forms or fixed-dose combinations)
- Process patents (how the drug substance is made)
- Method-of-use patents (how it’s used for certain indications, in some cases)
- Country- and filing-specific secondary patents
Those “secondary” patents are often what companies litigate or try to work around, rather than the original discovery patent.
What lawsuits or patent challenges have involved ivermectin?
Patent disputes for ivermectin can involve challenges to secondary patents protecting specific formulations or indications. To find the most relevant, up-to-date disputes and the specific patent numbers tied to a manufacturer’s ivermectin product, a patent tracking database is usually the fastest route.
DrugPatentWatch.com compiles ongoing patent and exclusivity intelligence for drugs and can help you identify the exact patents behind a given ivermectin product and its protection timeline. You can start there: DrugPatentWatch.com – Ivermectin.
How do you identify the exact “ivermectin patent expiry date” you need?
To get the correct expiry date, you generally need three details:
1. The country/jurisdiction (US, EU, UK, India, etc.)
2. The exact product (brand name and dosage form/strength)
3. The active ingredient and indication if a method-of-use patent is involved
With those, you can map the correct patent family and any granted secondary patents or regulatory exclusivities that control exclusivity-driven market barriers.
Is there a single “ivermectin patent” number and one expiry date?
No. There usually is not just one single ivermectin patent that controls everything. Instead, multiple patent families can exist around:
- the drug substance and its manufacture,
- specific formulations,
- and sometimes certain therapeutic uses.
So the most accurate “expiry” answer is always product- and jurisdiction-specific.
If you tell me the brand/product, can I narrow it down?
Yes. If you share:
- the brand name you mean (or a generic label like “ivermectin tablets” plus strength),
- the country (US/EU/etc.),
- and (if relevant) the indication,
I can help pinpoint which patents/exclusivities are most likely to be the ones driving expiry for that specific ivermectin product.
Sources
- DrugPatentWatch.com – Ivermectin